Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Pre-cancer”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Not applicableUnknownNCT04142463
What this trial is testing

Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2

Who this might be right for
Oncologic Disorders
Ilyse Kenis 500
Testing effectiveness (Phase 2)Study completedNCT01931098
What this trial is testing

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

Who this might be right for
GlioblastomaGlioblastoma MultiformeGliosarcoma+2 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT00490776
What this trial is testing

Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T-Cell Lymphoma
Novartis Pharmaceuticals 9
Testing effectiveness (Phase 2)Study completedNCT00003621
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 29
Testing effectiveness (Phase 2)Study completedNCT01716689
What this trial is testing

Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas

Who this might be right for
Sarcoma
National Cancer Centre, Singapore 24
Testing effectiveness (Phase 2)Study completedNCT00453336
What this trial is testing

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract

Who this might be right for
Head and Neck CancerPrecancerous/Nonmalignant Condition
University of Miami 45
Early research (Phase 1)UnknownNCT04477057
What this trial is testing

PhaseⅠStudy of the HS-10241 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd. 30
Early research (Phase 1)WithdrawnNCT00005030
What this trial is testing

SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Not applicableStudy completedNCT00507182
What this trial is testing

Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions

Who this might be right for
Oral Cancer
M.D. Anderson Cancer Center 381
Not applicableUnknownNCT04670146
What this trial is testing

Understanding Non-radiotherapy-based Development of Trismus

Who this might be right for
TrismusOral Cancer
KU Leuven 128
Early research (Phase 1)Ended earlyNCT02468661
What this trial is testing

A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification

Who this might be right for
Non-Small Cell Lung Cancer
Novartis Pharmaceuticals 23
Not applicableLooking for participantsNCT06406530
What this trial is testing

Topical Application of PRF Before Radiation Therapy

Who this might be right for
PRF
University of Giessen 34
Not applicableStudy completedNCT00342966
What this trial is testing

Characterization of the Pharmacokinetics of Oral Selenium Compounds in Humans Before and Following Supplementation

Who this might be right for
Cancer
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT02946671
What this trial is testing

Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients

Who this might be right for
Gastric CancerEsophageal CancerLung Cancer+2 more
Osaka University 16
Testing effectiveness (Phase 2)Study completedNCT00285701
What this trial is testing

Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study

Who this might be right for
Colorectal Cancer
Photocure 38
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Testing effectiveness (Phase 2)Study completedNCT04677595
What this trial is testing

Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals 37
Testing effectiveness (Phase 2)Ended earlyNCT02917629
What this trial is testing

ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment

Who this might be right for
Oral Cavity NeoplasmOropharyngeal NeoplasmStage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7+11 more
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05201066
What this trial is testing

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Novartis Pharmaceuticals 33
Load More Results